Australia's Holista CollTech rises on permit to sell COVID test kits in Malaysia

Holista Colltech

18/06/2021 04:14

** Shares of biotech co Holista CollTech  HCT.AX  rise as
much as 2.9% to A$0.07, their highest since March 16
    ** Co says it was granted permission to import and sell
SARS-CoV-2 rapid test kits in Malaysia  urn:newsml:reuters.com:*:nASX6qN3Bt
    ** The test kits are manufactured by Chinese diagnostic
device maker Guangdong Hecin Scientific Inc
    ** Stock on track to rise for a fourth consecutive session
    ** Stock down 5.6% this year, as of last close

 (Reporting by Soumyajit Saha in Bengaluru)
 ((Soumyajit.Saha@thomsonreuters.com;))